Induction vs. escalating therapy in Multiple Sclerosis: Practical implications

Neurological Sciences

Volumn 29, Issue SUPPL. 2, 2008, Pages

  Comi, Giancarlo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Early treatment; Escalation therapy; Immunomodulatory treatment; Immunosuppressive treatment; Induction therapy

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; GLATIRAMER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERFERON BETA SERINE; METHOTREXATE; MINOCYCLINE; MITOXANTRONE; NATALIZUMAB;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MULTIPLE SCLEROSIS; PROGNOSIS; TREATMENT PLANNING;

CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; MULTIPLE SCLEROSIS;

EID: 53649109121     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0954-x     Document Type: Article

References (9)

1. Comi G (2008) Clinically isolated syndrome: The rationale for early treatment. Nat Clin Pract Neurol 4:234-235
2. Mancardi G, Saccardi R (2008) Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 7:626-636
3. Zipoli V, Portaccio E, Hakiki B et al (2008) Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: An open label comparative study of efficacy and safety. J Neurol Sci 266:25-30
4. Engelhardt B, Kappos L (2008) Natalizumab: Targeting alpha4-integrins in multiple sclerosis. Neurodegener Dis 5:16-22
5. Talar-Williams C, Hijazi YM, Walther MM et al (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124:477-484
6. Ghalie RG, Mauch E, Edan G et al (2002) A study of therapyrelated acute leukaemia after mitoxantrone therapy for multiple sclerosis. Mult Scler 8:441-445
7. Rodegher M, Esposito F, Radaelli M et al (2007) Clinical and neuroradiological response to mitoxantrone in a large group of multiple sclerosis patients. J Neurol 254[Suppl 3]:O217
8. Debouverie M, Taillandier L, Pittion-Vouyovitch S et al (2007) Clincial follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment. Mult Scler 13:626-631
9. Cocco E, Marchi P, Sardu C et al (2007) Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis. Mult Scler 13:975-980